申请人:Alberati-Giani Daniela
公开号:US20050059668A1
公开(公告)日:2005-03-17
The invention relates to compounds of formula
wherein the substituents are as defined in the specification and to pharmaceutically acceptable acid addition salts thereof. The invention further relates to methods for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.
该发明涉及以下式中的化合物,其中取代基如规范中定义,并且其药用可接受的酸盐。该发明还涉及治疗精神病、疼痛、记忆和学习中的神经退行性功能障碍、精神分裂症、痴呆症以及其他认知过程受损的疾病的方法,如注意力缺陷障碍或阿尔茨海默病。